Impact of Citalopharm and Fluvoxamine on Platelet Response to Clopidogrel
This study has been completed.
Hadassah Medical Organization
Information provided by (Responsible Party):
RONNY ALCALAI, Hadassah Medical Organization
First received: July 14, 2011
Last updated: January 26, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||December 2012|
|Primary Completion Date:||December 2012 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Hirsh-Rokach B, Spectre G, Shai E, Lotan A, Ritter A, Al-Aieshy F, Malmström RE, Varon D, Alcalai R. Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial. Pharmacotherapy. 2015 Feb;35(2):140-7. doi: 10.1002/phar.1542.